Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1960 1
1961 1
1962 4
1964 1
1965 1
1966 1
1967 2
1968 2
1969 3
1970 2
1972 1
1974 3
1977 6
1978 4
1980 3
1981 2
1982 4
1984 1
1985 1
1988 2
1991 1
1992 1
1993 1
1994 1
1995 2
1997 3
1998 3
1999 2
2000 3
2001 1
2004 2
2005 3
2006 2
2007 3
2008 4
2009 3
2010 5
2011 3
2012 5
2013 7
2014 4
2015 4
2016 8
2017 1
2018 3
2019 7
2020 12
2021 18
2022 14
2023 17
2024 9
2025 9
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.
Rolke R, Baron R, Maier C, Tölle TR, Treede -DR, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Rolke R, et al. Among authors: schaub c. Pain. 2006 Aug;123(3):231-243. doi: 10.1016/j.pain.2006.01.041. Epub 2006 May 11. Pain. 2006. PMID: 16697110
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: schaub c. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R, Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC, Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten M, Glas M, Seidel C, Herrlinger U, Hölzel M. Giordano FA, et al. Among authors: schaub c. Nat Commun. 2024 May 28;15(1):4210. doi: 10.1038/s41467-024-48416-9. Nat Commun. 2024. PMID: 38806504 Free PMC article. Clinical Trial.
T-Box Genes in Drosophila Mesoderm Development.
Reim I, Frasch M, Schaub C. Reim I, et al. Among authors: schaub c. Curr Top Dev Biol. 2017;122:161-193. doi: 10.1016/bs.ctdb.2016.06.003. Epub 2016 Jul 30. Curr Top Dev Biol. 2017. PMID: 28057263 Review.
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma.
Schneider M, Potthoff AL, Ahmadipour Y, Borger V, Clusmann H, Combs SE, Czabanka M, Dührsen L, Etminan N, Freiman TM, Gerlach R, Gessler F, Giordano FA, Gkika E, Goldbrunner R, Güresir E, Hamou H, Hau P, Ille S, Jägersberg M, Keric N, Khaleghi-Ghadiri M, König R, Konczalla J, Krenzlin H, Krieg S, McLean AL, Layer JP, Lehmberg J, Malinova V, Meyer B, Meyer HS, Miller D, Müller O, Musahl C, Pregler BEF, Rashidi A, Ringel F, Roder C, Rössler K, Rohde V, Sandalcioglu IE, Schäfer N, Schaub C, Schmidt NO, Schubert GA, Seidel C, Seliger C, Senft C, Shawarba J, Steinbach J, Stöcklein V, Stummer W, Sure U, Tabatabai G, Tatagiba M, Thon N, Timmer M, Wach J, Wagner A, Wirtz CR, Zeiler K, Zeyen T, Schuss P, Surges R, Fuhrmann C, Paech D, Schmid M, Borck Y, Pietsch T, Struck R, Radbruch A, Helmstaedter C, Németh R, Herrlinger U, Vatter H. Schneider M, et al. Among authors: schaub c. BMC Cancer. 2025 Feb 20;25(1):306. doi: 10.1186/s12885-025-13682-3. BMC Cancer. 2025. PMID: 39979825 Free PMC article.
Clostridium innocuum endocarditis.
Cutrona AF, Watanakunakorn C, Schaub CR, Jagetia A. Cutrona AF, et al. Among authors: schaub cr. Clin Infect Dis. 1995 Nov;21(5):1306-7. doi: 10.1093/clinids/21.5.1306. Clin Infect Dis. 1995. PMID: 8589163 Review.
Current status of precision oncology in adult glioblastoma.
Weller J, Potthoff AL, Zeyen T, Schaub C, Duffy C, Schneider M, Herrlinger U. Weller J, et al. Among authors: schaub c. Mol Oncol. 2024 Dec;18(12):2927-2950. doi: 10.1002/1878-0261.13678. Epub 2024 Jun 20. Mol Oncol. 2024. PMID: 38899374 Free PMC article. Review.
196 results